Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Growth Equity Opportunities Fund, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/29/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/13/2014 SC 13D/A Growth Equity Opportunities Fund, LLC reports a 10.6% stake in Sunesis Pharmaceuticals, Inc.
08/12/2014 4 Growth Equity Opportunities Fund, LLC (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC
Txns: Sold 675,000 shares @ $6.6201, valued at $4.5M
Sold 35,540 shares @ $6.7583, valued at $240.2k
01/31/2014 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/13/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/13/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/21/2011 SC 13D/A Growth Equity Opportunities Fund, LLC has filed a Schedule 13D for ARYx Therapeutics, Inc.
03/14/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
02/07/2011 SC 13G/A Growth Equity Opportunities Fund, LLC reports a 6% stake in Orexigen Therapeutics, Inc.
07/09/2010 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
07/02/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/05/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
01/15/2010 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
11/17/2009 SC 13D Growth Equity Opportunities Fund, LLC reports a 36.7% stake in Sunesis Pharmaceuticals, Inc.
09/17/2009 SC 13D Growth Equity Opportunities Fund, LLC reports a 8.2% stake in NeuroMetrix, Inc.
04/13/2009 SC 13D Form SC 13D -- General statement of acquisition of beneficial ownership
04/06/2009 3 Form 3 -- Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy